awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26828930-F3305D7A-8523-4DFD-8666-D218BB63B209
Q26828930-F3305D7A-8523-4DFD-8666-D218BB63B209
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26828930-F3305D7A-8523-4DFD-8666-D218BB63B209
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
P2860
Q26828930-F3305D7A-8523-4DFD-8666-D218BB63B209
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26828930-F3305D7A-8523-4DFD-8666-D218BB63B209
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14bf14eb430f96c3197680abc21ee7622785b401
P2860
Lessons from phase III clinical trials on anti-VEGF therapy for cancer.